Table II.
Clinical outcome of control children participating in the WP1-UKER cohort in the European PreDicta study
| Group/patient | Age (y) | Sex | PBMCs (106 cells/mL of blood) | Skin prick test | FEV1 actual value (%) | Cigarette exposure/d | No. of symptomatic episodes before B0 |
|---|---|---|---|---|---|---|---|
| Healthy subjects | |||||||
| 1 | 6 | M | 1.14 | ND | — | 0 | — |
| 2 | 6 | F | 2.95 | ND | 121 | 0 | — |
| 3 | 5 | F | 1.79 | Negative | 81 | 0 | — |
| 4 | 4 | M | 2.01 | ND | — | 0 | — |
| 5 | 6 | M | 1.41 | ND | 105 | 0 | — |
| 6 | 4 | F | 2.14 | ND | 109 | 0 | — |
| 7 | 6 | M | 2.86 | ND | 87 | 0 | — |
| 8 | 4 | M | 1.73 | Negative | 100 | 0 | — |
| 9 | 5 | F | 1.67 | ND | 112 | 0 | — |
| 10 | 5 | F | 2.01 | Positive | 119 | 0 | — |
| 11 | 4 | M | 2.43 | Positive | 116 | 0 | — |
| 12 | 5 | M | 2.32 | ND | 111 | 0 | — |
| 13 | 4 | M | 2.40 | Negative | 109 | 0 | — |
| 14 | 4 | F | 1.60 | Negative | 109 | 0 | — |
| 15 | 5 | M | 2.22 | Negative | 92 | 0 | — |
| 16 | 4 | M | 2.88 | Negative | — | 0 | — |
| 17 | 4 | M | 1.38 | Negative | 109 | 0 | — |
| 18 | 5 | M | 1.13 | ND | 110 | 0 | — |
| 19 | 4 | M | 1.77 | ND | 118 | 0 | — |
| 20 | 5 | F | 1.50 | ND | — | 0 | — |
| Mean | 4.75 | 13 M | 1.97 | 106.75 | 0 | ||
| SEM | 0.17 | 7 F | 0.12 | 2.48 | 0 | ||
B0, Baseline visit; F, female; M, male; ND, not done; UKER, Uniklinikum Erlangen; WP1, Work Program 1.